Annette Tumolo Bio Rad Laboratories, Inc. (BIO) insider trading activity

Annette Tumolo is Executive Vice President of BIO-RAD LABORATORIES, INC.. Currently has a direct ownership of 4,593 shares of BIO, which is worth approximately $1.49 Million. The most recent transaction as insider was on Nov 12, 2021, when has been sold 4,800 shares (Bio-Rad A Common Stock) at a price of $750.05 per share, resulting in proceeds of $3,600,240. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.59K

0% 3M change

0% 12M change

Total Value Held $1.49 Million

ANNETTE TUMOLO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 12 2021	SELL Open market or private sale	$3,600,240 $750.05 p/Share	4,800 Reduced 51.1%	4,593 Bio-Rad A Common Stock
Nov 12 2021	BUY Exercise of conversion of derivative security	$1,122,336 $233.82 p/Share	4,800 Added 33.82%	9,393 Bio-Rad A Common Stock
Nov 11 2021	SELL Open market or private sale	$1,157,908 $748.97 p/Share	1,546 Reduced 25.18%	4,593 Bio-Rad A Common Stock
Nov 11 2021	BUY Exercise of conversion of derivative security	$613,747 $396.99 p/Share	1,546 Added 20.12%	6,139 Bio-Rad A Common Stock
Sep 07 2021	SELL Payment of exercise price or tax liability	$240,283 $806.32 p/Share	298 Reduced 6.09%	4,593 Bio-Rad A Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	-	600 Added 10.93%	4,891 Bio-Rad A Common Stock
Sep 05 2021	SELL Payment of exercise price or tax liability	$244,271 $819.7 p/Share	298 Reduced 6.49%	4,291 Bio-Rad A Common Stock
Sep 05 2021	BUY Exercise of conversion of derivative security	-	600 Added 11.56%	4,589 Bio-Rad A Common Stock
Sep 04 2021	SELL Payment of exercise price or tax liability	$244,271 $819.7 p/Share	298 Reduced 6.95%	3,989 Bio-Rad A Common Stock
Sep 04 2021	BUY Exercise of conversion of derivative security	-	600 Added 12.28%	4,287 Bio-Rad A Common Stock
Sep 03 2021	SELL Payment of exercise price or tax liability	$206,564 $819.7 p/Share	252 Reduced 6.4%	3,687 Bio-Rad A Common Stock
Sep 03 2021	BUY Exercise of conversion of derivative security	-	557 Added 12.39%	3,939 Bio-Rad A Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$123,866 $825.77 p/Share	150 Reduced 4.25%	3,382 Bio-Rad A Common Stock
Sep 02 2021	BUY Exercise of conversion of derivative security	-	433 Added 10.92%	3,532 Bio-Rad A Common Stock
Aug 26 2021	SELL Open market or private sale	$475,548 $792.58 p/Share	600 Reduced 16.22%	3,099 Bio-Rad A Common Stock
Nov 09 2020	SELL Bona fide gift	-	423 Reduced 10.26%	3,699 Bio-Rad A Common Stock
Nov 06 2020	SELL Open market or private sale	$768,768 $640.64 p/Share	1,200 Reduced 22.55%	4,122 Bio-Rad A Common Stock
Nov 06 2020	BUY Exercise of conversion of derivative security	$191,184 $159.32 p/Share	1,200 Added 18.4%	5,322 Bio-Rad A Common Stock

Also insider at

DNAY

Codex DNA, Inc. Healthcare

Annette Tumolo

Executive Vice President

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-RAD LABORATORIES, INC.

Track Activities on BIO

Account